| Jan 26, 2026 | Jixing Pharmaceuticals | $287.0M Series D | — | HBM Healthcare Investments, Hengdian Group Capital, Invus, RA Capital Management, Roderick Wong, Silver Arc Private Capital, SR One, SymBiosis, TCGX |
| Jan 12, 2026 | Mirador Therapeutics | $250.0M Series B | — | ARCH Venture Partners, Boxer Capital, Fairmount, Farallon Capital Management, Fidelity Management & Research Company, Invus, Logos Capital, OrbiMed, Point72, TCGX, T. Rowe Price Associates, Venrock, Woodline Partners |
| Dec 16, 2025 | Ambros Therapeutics | $125.0M Series A | Trit Garg, Matthew Hammond | Massimo Di Martino, Arkin Bio Ventures, Balyasny Asset Management, Janus Henderson Investors, Transhuman Capital |
| Oct 1, 2025 | Kailera Therapeutics | $600.0M Series B | Andrew Kaplan | Bain Capital, Gotham Makker, Michael Gladstone, Atlas Venture, Bain Capital Life Sciences, Invus, Janus Henderson Investors, Perseverance Capital Management, Qatar Investment Authority, Royalty Pharma, Roderick Wong, Sirona Capital, Surveyor Capital, T. Rowe Price Associates |
| Sep 10, 2025 | PsiQuantum | $1.0B Series E | Tony Kim, Temasek | Michael Tolo, 1789 Capital, Macquarie Capital, Morgan Stanley, NVentures, Qatar Investment Authority, Ribbit Capital, S Ventures, Third Point Ventures, T. Rowe Price Associates, Type One Ventures |
| Apr 12, 2024 | Century Therapeutics | $60.0M Other Equity | Adage Capital Management, Bain Capital Life Sciences, Octagon Capital, Superstring Capital | Boxer Capital, Casdin Capital, Dafna Capital, Venrock |
| Mar 17, 2024 | LEXEO Therapeutics | $95.0M Other Equity | Adage Capital Management, Braidwell | — |
| Feb 29, 2024 | Avidity Biosciences | $400.0M Other Equity | — | Boxer Capital, Casdin Capital, Farallon Capital Management, Janus Henderson Investors, RA Capital Management, RTW Investments, Wellington Management |
| Jul 1, 2023 | HawkEye 360 | $58.0M Series D | Matthew Singer | AllegisCyber Capital, Alumni Ventures, ARCH Venture Partners, Baukunst, Foundry Group, General Atlantic, H.I.G. Capital, Lockheed Martin Ventures, Madrona Ventures, Northpond Ventures, OurCrowd, Razor's Edge Ventures, Gil Penchina, Sapphire Ventures, Shield Capital, Space Capital, Chaim Meir Tessler, Will Herman, Alumni Ventures, Insight Partners, Jared Carmel, NightDragon, Tawazun Council |
| Apr 26, 2022 | Harness | $230.0M Debt / Series D | Rama Sekhar | IVP, Alkeon Capital, Balyasny Asset Management, Battery Ventures, Capital One Ventures, Citi Ventures, Gaingels, Google Ventures, Harmonic Growth Partners, J.P. Morgan, Menlo Ventures, Philip Kirk, Silicon Valley Bank, Sorenson Capital, Splunk Ventures, Thomvest Ventures, Unusual Ventures |
| Mar 1, 2022 | Menlo Micro | $150.0M Series C | Future Shape, Vertical Venture Partners | 2150, ARCH Venture Partners, Vasudev Bailey, Blisce, Breakthrough Energy Ventures, DBL Partners, Evolution Equity Partners, Greylock, Kima Ventures, Microsoft, Paladin Capital Group, Pareto Holdings, Piva Capital, Prelude Ventures, Saudi Aramco Energy Ventures, Section 32, The Engine, Uncork Capital, Bradley Horowitz, Fidelity Management & Research Company |
| Nov 1, 2021 | HawkEye 360 | $150.0M Series D | Insight Partners, Mark Boggett | AllegisCyber Capital, Alumni Ventures, ARCH Venture Partners, Baukunst, Lockheed Martin Ventures, Northpond Ventures, Razor's Edge Ventures, Shield Capital, Space Capital, 116 Street Ventures, Advance Publications, Gula Tech Adventures, Jacobs, New North Ventures, NightDragon, SVB Capital |
| Nov 1, 2021 | Antios Therapeutics | $75.0M Series B | EPIQ Capital Group, Craig Gordon | Domain Associates, Pontifax Venture Capital, Aisling Capital, Altium Capital, Amzak Health, Avego Bioscience Capital, CAM Capital, Delos Capital, Granite Point Capital, GRA Venture Fund, Heartland Healthcare Capital, LifeSci Venture Partners, Lumira Ventures, RA Capital Management, Sixty Degree Capital, Soleus Capital |
| Oct 1, 2021 | Scout Bio | $33.0M Series B | — | Abingworth, Bain Capital Life Sciences, Digitalis Ventures, MRL Ventures Fund, RiverVest, SV Health Investors, Correlation Ventures, Frazier Healthcare Partners, Greenspring Associates, OrbiMed, RiverVest Venture Partners |
| Oct 1, 2021 | CinCor Pharma | $140.0M Series B | Jason Pitts | ARCH Venture Partners, Keno Gutierrez, Soffinova Partners, Sofinnova Investments, Third Rock Ventures, Westlake Village BioPartners, David Morris, Heather Preston, BVF Partners, CinCor Pharma, CinRx Pharma, Lilly Asia Ventures, Omega Funds, Perceptive Advisors, Rock Springs Capital, RTW Investments, Sixty Degree Capital |
| Aug 5, 2021 | Pepgen | $112.5M Other Equity | — | CureDuchenne Ventures, Deerfield Management, Gray's Creek Capital Partners, Laurion Capital Management, Alexis Dormandy, Joshua Resnick, Samsara BioCapital, Tudor Ventures, Viking Global Investors |
| Aug 1, 2021 | Beckley Psytech | $80.0M Series B | Jay Newmark | re.Mind Capital, Satori Capital, What If Ventures, Bicycle Day Ventures, Delphi VC, Leafy Tunnel, Negev Capital, Palo Santo, Amy Kruse |
| Jul 30, 2021 | Gopuff | $1.0B Other Equity | — | Atreides Management, Blackstone, Fidelity Management & Research Company, Scott Minerd, Ian Osborne, MSD Partners, SoftBank |
| Jun 24, 2021 | GOAT Group | $195.0M Series F | Adage Capital Management, Franklin Templeton, Park West Asset Management, T. Rowe Price Associates, Ulysses Management | — |
| Jun 24, 2021 | Goat | $195.0M Series F | Adage Capital Management, Franklin Templeton, Tyras Bookman, T. Rowe Price Associates, Ulysses Management | — |
| Jun 19, 2021 | ViaCyte | $45.0M Series D | — | Asymmetry Ventures, Bain Capital Life Sciences, Invus, RA Capital Management, Sanderling Ventures, TPG |
| May 23, 2021 | Arch Oncology | $105.0M Series C | Joe Biller, CFA, Eric Pham, Joy Ghosh | Avego Healthcare Capital, Broadfin Holdings, FMB Research, Lightchain, Point72, John McKearn, Roche |
| May 1, 2021 | Forter | $300.0M Series F | John Curtius | 83North, Accel, Afore Capital, Alpha Prime Fund, Altair Capital Management, Atomico, Bain Capital, Bain Capital Ventures, Benchmark, Bessemer Venture Partners, Blumberg Capital, Citi Ventures, Commerce Ventures, Company Capital, Dell Technologies Capital, Energize Ventures, Energy Impact Partners, Flint Capital, General Atlantic, HC9 Ventures, H.I.G. Capital, Kleiner Perkins, L Catterton Growth, Lightspeed Venture Partners, March Capital, Menlo Ventures, Momenta Ventures, Mouro Capital, MS&AD Ventures, Colin Bryant, NewView Capital, Operator Stack, OurCrowd, Owl Rock Capital Partners, Propeller VC, Scale Venture Partners, Sequoia Capital Israel, Work-Bench, Amit Jhawar, Dimiter Tschawow, Mato Peric, Noah Pickholtz, Stefan Smalla, Ziv Kop, Salesforce Ventures, Sequoia Capital, Daniel Loeb |
| May 1, 2021 | SiMa.ai | $80.0M Series B | Fidelity Management & Research Company | Amplify Partners, Dell Technologies Capital, Mayfield, Msd Capital, Walden International, Wing Venture Capital, Alter Venture Partners, NanoDimension |
| Apr 1, 2021 | Antios Therapeutics | $96.0M Series B | Guy Levy | Domain Associates, Michele Park, Pontifax Venture Capital, Sanofi Ventures, Aisling Capital, Amzak Health, CAM Capital, Delos Capital, Granite Point Capital, LifeSci Venture Partners, Lumira Ventures, RA Capital Management, Sixty Degree Capital |
